Figure 2From: Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collaborative retrospective multicenter clinical review of 1,082 patients Comparison of survival curves in pancreatic cancer. a. Comparison of survival curves among clinical stages in patients with pancreatic cancer (n = 1,082). MST, median survival time. b. Comparison of survival curves among different treatments in patients with pancreatic cancer (n = 1,082). MST, median survival time; OP, operation; CT, chemotherapy; BSC, best supportive care.Back to article page